Cystic Fibrosis News Today Forums Forums Science and Research CF Foundation Awards Eloxx $1.61M to Support Nonsense Mutation Research

  • CF Foundation Awards Eloxx $1.61M to Support Nonsense Mutation Research

    Posted by cystic-fibrosis-news-moderator on October 1, 2019 at 7:33 pm

    The Cystic Fibrosis Foundation (CFF) is giving Eloxx Pharmaceuticals up to $1.61 million to support its planned Phase 2 clinical trial program assessing the safety, tolerability, and chemical properties of ELX-02, Eloxx’s lead investigational compound to treat cystic fibrosis (CF) caused by nonsense, or stop, mutations.

    The program is set to include two open-label, dose escalation, Phase 2 trials. One, called EL-012, will enroll up to eight patients in the U.S.; the other, EL-004, will enroll up to 16 patients in Europe. Click here to learn more about it.

    What do you think of this research?

  • 0 Replies

Sorry, there were no replies found.

Log in to reply.